On 11/15/24, REGENXBIO Inc (NASDAQ: RGNX) stock suffered a major decline of -13.6%, closing at $9.63. Moreover, this decline was accompanied by exceptionally high trading volume at 216% of normal. Relative to the market the stock has been extremely weak over the last nine months and has declined -13.9% during the last week.
Current PriceTarget Research Rating
REGENXBIO has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing highly consistent signals. REGENXBIO has a poor Appreciation Score of 28 and a poor Power Rating of 21, resulting in the Lowest Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment